Skip to main content
. 2022 Sep 19;7(38):34476–34484. doi: 10.1021/acsomega.2c04148

Figure 5.

Figure 5

Biocompatibility study of the (a) crude or naïve form and (b) nanosized form of naringenin as carried out in hTERT-BJ (human skin fibroblast) cell lines for a period of 24 and 48 h.